Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Michèle Noël"'
Autor:
Marie-Elisabeth Toubert, Dominique Luton, Brigitte Tébeka, Michel Polak, Paul Czernichow, Jean Guibourdenche, Marie-Hélène Schlageter, Michèle Noël, Juliane Léger, Mireille Castanet, Jean-François Oury, Isabelle Le Gac, Edith Vuillard, Christine Boissinot, Catherine Garel
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 90:6093-6098
Background: Fetuses from mothers with Graves’ disease may experience hypothyroidism or hyperthyroidism due to transplacental transfer of antithyroid drugs (ATD) or anti-TSH receptor antibodies, respectively. Little is known about the fetal conseque
Publikováno v:
Current Opinion in Clinical Nutrition and Metabolic Care. 4:399-405
Insulin-like growth factor-I circulates in serum either in free form or bound to insulin-like growth factor-binding proteins that modulate its bioavailability. Insulin-like growth factor-binding proteins interfere with insulin-like growth factor-I as
Publikováno v:
Nutrition Clinique et Métabolisme. 14:5-23
Resume Au cours du vieillissement, il existe une diminution globale de l'activite de l'axe somatotrope ; ce phenomene est appele somatopause. Il associe une diminution de la secretion de GH par l'hypophyse a une resistance peripherique a cette hormon
Publikováno v:
BJOG: An International Journal of Obstetrics and Gynaecology. 112:1565-1567
Graves' disease and thyroid dysfunction during pregnancy can lead to maternal and fetal complications. No information is available on thyroid function in women with a past history of Graves' disease. We compared free T3, free T4 and TSH in a group of
Publikováno v:
European Journal of Pediatrics. 155:688-694
Twelve prepubertal children with chronic renal failure (CRF) were treated with human growth hormone (GH) (1.2 IU/kg/week) for 2 years. High doses of GH clearly increased growth velocity, from 3.8 +/- 1.3 to 9.6 +/- 1.5 (P = 0.0001) and 6.9 +/0 0.8 cm
Publikováno v:
Pediatric Research. 40:101-107
The aim of this study was to describe serum GH, IGF-I, and IGF binding protein (BP) 3 levels at birth and during the first 2 y of life in intrauterine growth-retarded (IUGR) children and to correlate these hormonal values with auxologic parameters no
Autor:
Michèle Noël, Karim Benali, Sabine Baron, Jean-François Oury, Paul Czernichow, Philippe Blot, Juliane Léger
Publikováno v:
Pediatric Research. 40:94-100
The aim of this study was to relate human fetal growth retardation to specific hormone alterations. Serum levels of GH, IGF-I, IGF-II, and IGF binding protein (BP) 3 were measured during the second half of gestation after cordocentesis in 230 fetuses
Publikováno v:
Pediatric Research. 37:731-735
The short- and long-term effects of hGH treatment on growth hormone (GH)-binding protein (GHBP) were examined in 18 prepubertal children, aged 1.5–10 y, with isolated idiopathic GH deficiency. The patients were studied before and at regular interva
Publikováno v:
Hormone Research. 44:57-63
We measured urinary growth hormone (U-GH) excretion to estimate the spontaneous growth hormone (GH) production in normal children according to age, sex, height, body mass index, serum insulin-like growth factor-1 (IGF-1), and pubertal status. To asse
Publikováno v:
Clinical Biochemistry. 33:679-681